Trials / Completed
CompletedNCT05317845
An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and Africa
A Multi-center, Cross-sectional Chart Review and Survey to Capture the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and Africa
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,089 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is intended to estimate the proportion and clinical management of people with type 2 diabetes having atherosclerotic cardiovascular diseases or who are at high risk to develop atherosclerotic cardiovascular diseases. Participants will be asked to give information about their health. Partipants will continue normal way of life and will not get any medication other than those prescribed to them by the doctor. The study will last for about 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | The clinical management and prescribed treatment of diabetes and eASCVD/ASCVD risk factors are independent of this study and are part of the routine clinical practice at the discretion of the treating physician. |
Timeline
- Start date
- 2022-04-21
- Primary completion
- 2022-08-31
- Completion
- 2022-08-31
- First posted
- 2022-04-08
- Last updated
- 2023-03-28
Locations
7 sites across 7 countries: Bahrain, Egypt, Jordan, Kuwait, Qatar, South Africa, United Arab Emirates
Source: ClinicalTrials.gov record NCT05317845. Inclusion in this directory is not an endorsement.